The retail space is rapidly evolving today, as bricks-and-mortar retailers such as Target (NYSE: TGT ) and Wal-Mart (NYSE: WMT ) attempt to compete with e-commerce giant Amazon.com (NASDAQ: AMZN ) in an increasingly competitive market. From smaller store formats to same-day delivery methods, retailers of every variety are experimenting with new ways to drive sales. Today, some of our Motley Fool contributors will discuss three retail trends that are transforming the industry.
Rich Duprey: One of the biggest trends in retailing today is reducing the footprint of stores. Wal-Mart is arguably the best example of retailers shrinking the size of their physical locations, as it has experimented with formats ranging from as small as 15,000 square feet for its Walmart Express convenience store-style format to 40,000-square-foot Neighborhood Markets, more akin to your local supermarket than the typical 180,000-square-foot Supercenter.
Yet it's not alone, as Target has been similarly experimenting with small format stores, having opened an urban-oriented CityTarget concept that's about two-thirds the size of the typical 130,000-square-foot Target store, and a TargetExpress this past summer that clocks in at 20,000 square feet.
Top Oil Companies To Watch In Right Now: Antares Pharma Inc (ATRS)
Antares Pharma, Inc. (Antares) is a pharma company that focuses on self-injection pharmaceutical products and technologies and topical gel-based products. The Company�� subcutaneous and intramuscular injection technology platforms include Vibex disposable pressure-assisted auto injectors, Vision reusable needle-free injectors, and disposable multi-use pen injectors. In the injector area, it has licensed its reusable needle-free injection device for use with human growth hormone (hGH) to Teva, Ferring Pharmaceuticals BV (Ferring) and JCR Pharmaceuticals Co., Ltd. (JCR), with Teva and Ferring being its two primary customers. The Company has also licensed both disposable auto and pen injection devices to Teva for use in certain fields and territories and is engaged in product development activities for Teva utilizing these devices.
In the gel-based area, it received Food and Drug Administration (FDA) approval in December 2011 for its oxybutynin gel 3% product, Anturol, for the treatment of overactive bladder. Antares also has a licensing agreement with Watson Watson Pharmaceuticals, Inc. (Watson) under which Watson will commercialize its topical oxybutynin gel 3% product in the United States and Canada. Its gel portfolio also includes Elestrin (estradiol gel) in the United States for the treatment of moderate-to-severe vasomotor symptoms associated with menopause. Antares has designed disposable, pressure assisted auto injector devices to address acute medical needs, such as allergic reactions, migraine headaches, acute pain, emesis and other daily therapies.
Pressure Assisted Injection Devices
The Company�� Pressure Assisted Injection Devices consists of three products: reusable needle-free injectors, disposable pressure assisted auto injectors and disposable pen injectors. Reusable needle-free injectors deliver precise medication doses through high-speed, pressurized liquid penetration of the skin without a needle. The injector employs a disposable pl! astic needle-free syringe, which offers liquid medication delivery through an opening that is approximately half the diameter of a standard, 30-gauge needle.
Disposable pressure assisted auto injectors is a technology of controlled pressure delivery of drugs into the body utilizing a spring power source. The Vibex is designed to provide fast subcutaneous or intramuscular injections of up to 0.5ml with minimal discomfort and improved convenience in conjunction with the enhanced safety of a shielded needle. Disposable pen injectors are needle-based devices designed to deliver multiple injections from multi-dose drug cartridges. The devices contain mechanisms that specify the dose to be delivered by defining the amount of movement by the stopper in the cartridge with each device actuation.
The Vision/Tjet has been sold for use in more than 30 countries to deliver either insulin or hGH. The product features a reusable, spring-based power source and disposable needle-free syringe, which acts as the pathway for the injectable drug through the skin and allows for viewing of the medication dose prior to injection. The product is also reusable, with each device designed to last for approximately 3,000 injections (or approximately two years) while the needle-free syringe, when used with insulin or hGH, is disposable after approximately one week when used by a single patient for injecting from multi-dose vials. The Vision/Tjet administers injectables by using a spring to push the active ingredient in solution or suspension through a micro-fine opening in the needle-free syringe. The opening is approximately half the diameter of a 30-gauge needle. The Vision/Tjet is primarily used in the United States, Europe, Asia and Japan.
Antares has designed disposable, pressure assisted auto injector devices to address acute medical needs, such as allergic reactions, migraine headaches, acute pain, emesis and other daily therapies. Its Vibex disposable product combines a low-energy, spr! ing-based! power source with a hidden needle, which delivers up to 0.5ml of the needed drug solution subcutaneously or intramuscularly. Antares is also developing a Vibex MTX auto injector for delivery of methotrexate for treatment of rheumatoid arthritis. The Company�� multi use, disposable pen injector complements its portfolio of single-use pressure assisted auto injector devices. The disposable pen injector device is designed to deliver drugs by injection through needles from multi- dose cartridges. The disposable pen is in the stage of development where devices are being used in clinical evaluations.
Transdermal Products
The Company�� ATD system penetrates the skin to deliver a variety of treatments. The gels consist of a hydro-alcoholic base, including a combination of permeation enhancers. Products being developed/ commercialized include Anturol, Elestrin and Nestragel. Elestrin is a transdermal estradiol gel for the treatment of moderate-to-severe vasomotor symptoms associated with menopause. Its other injectable drugs that are presently self-administered and may be suitable for injection with its systems include therapies for the prevention of blood clots and treatments for multiple sclerosis, migraine headaches, inflammatory diseases, impotence, infertility, acquired immune deficiency symdrome (AIDS) and hepatitis.
The Company competes with Ypsomed AG, SHL Group AB, OwenMumford Ltd., West Pharmaceuticals, Becton Dickinson, Haselmeir GmbH, Elcam Medical, Vetter Pharma, Bioject Medical Technologies Inc., The Medical House PLC, Watson, Abbott, Eli Lilly, Auxillium, Inc., Endo Pharmaceuticals, Teva, Mylan, Roxane, Bedford Labs, APP Pharmaceuticals, Hospira, Pfizer, GSK/Astellas, Warner Chilcott and Allergan.
Advisors' Opinion:- [By Luke Jacobi]
Antares Pharma (NASDAQ: ATRS) added 6.65 percent to close at $4.33 following the announcement that an FDA decision is expected on its drug on October 14. Equities
- [By Monica Gerson]
Antares Pharma (NASDAQ: ATRS) shares tumbled 3.09% to touch a new 52-week low of $3.14. Antares Pharma's PEG ratio is -0.29.
eGain (NASDAQ: EGAN) shares fell 3.76% to reach a new 52-week low of $6.40. eGain's trailing-twelve-month ROE is -8.92%
- [By Keith Speights]
1. Antares Pharma (NASDAQ: ATRS )
Antares has experienced a roller-coaster ride so far this year. The stock was up more than 10% early in January, then proceeded to fall by more than 20% by late February. Since then, Antares has clawed its way back and now stands up a little over 10% for the year.� - [By Keith Speights]
Antares Pharma (NASDAQ: ATRS ) announced its first-quarter results �Wednesday morning but failed to impress the market. Shares were down around 3% in midday trading. Here are the highlights from the company's results.
5 Best Supermarket Stocks To Watch For 2014: Peapack-Gladstone Financial Corporation(PGC)
Peapack-Gladstone Financial Corporation operates as the holding company for Peapack-Gladstone Bank that provides financial, trust, and investment services to individuals and small businesses in New Jersey. The company?s deposit products include checking and savings accounts, money market and interest-bearing checking accounts, certificates of deposit, and individual retirement accounts. Its loan portfolio comprises residential and construction mortgages, home equity lines of credit, and other second mortgage loans, as well as commercial loans, including working capital lines of credit, term loans for fixed asset acquisitions, commercial mortgages, and other forms of asset-based financing. The company also provides foreign and domestic travelers? checks, cashier?s checks, wire transfers, Internet banking, and automated teller machine services. In addition, it offers personal investment management, personal trust administration, estate settlement, income tax, custodial, a nd other financial planning services. Peapack-Gladstone Financial Corporation provides its services through 23 full-service banking offices, including 10 branches in Somerset County, 6 in Morris County, 4 in Hunterdon County, 1 in Middlesex County, and 2 in Union County. The company was founded in 1921 and is based in Bedminster, New Jersey.
Advisors' Opinion:- [By Alex Planes]
Since that prediction, Honeywell's begun to branch out in unexpected ways, as it's now working with utilities such as PG&E (NASDAQ: PGC ) to provide residential energy-management platforms. The "smart grid" is growing in fits and starts, but it's one of the more optimistic corners of tomorrow's economy, so it's good for Honeywell investors to see the company dipping a toe in these waters.
5 Best Supermarket Stocks To Watch For 2014: Bonavista Energy Corp (BNPUF.PK)
Bonavista Energy Corporation (Bonavista) is engaged in the acquisition, exploration, development and production of oil and natural gas assets. The Company operates approximately 87% of its assets which are concentrated within three core regions in western Canada. Each core region contains a well-balanced portfolio of oil and natural gas assets with considerable opportunities. Its operations are geographically focused within three regions of Western Canada, which includes Western region, Northern region and Eastern region. The Company�� subsidiaries include Bonavista Petroleum (BP), Bonavista Energy LP (BELP) and Bonavista Energy Inc. (BEI). Advisors' Opinion:- [By Stephan Dube]
Cold Lake's most notable producers:
Husky Energy (HUSK.PK), see article here.Pengrowth Energy Corporation (PGH), see article here.Southern Pacific Resource (STPJF.PK), see article here.Canadian Natural Resources (CNQ), see article here.Devon Energy (DVN), see article here.Imperial Oil (IMO), see article here.Baytex, see article here.Bonavista Energy (BNPUF.PK), see article here.Athabasca's most notable producers:
5 Best Supermarket Stocks To Watch For 2014: Soditech Ingenierie SA (SEC)
Soditech Ingenierie SA is a France-based company that is primarily engaged in electronic and mechanical engineering services in various sectors. The Company�� activity is organized into three sectors: Defense & Research, Space and Energy & Nuclear. It provides specialized services in four fields: aerospace, covering communication satellites, observation satellites and space stations; automotive, providing such services as engine design and plasturgy for equipment manufacturers; aeronautics, offering structural research for aircraft makers, instruments or electro-mechanical systems for assisting pilots and others, and defense, providing engineering of numerous tests and trials systems, with or without implementations, among others. The Company also offers additional services, such as energy forecasting and environmental analysis, environmental management system, and others. In May 2014, it restructured company into three main divisions: Defense & Research, Space and Energy & Nuclear. Advisors' Opinion:- [By ovenerio]
Over the past days hedge funds have been filing their form 13-F, which is a quarterly report of equity holdings by filed institutional investment managers with at least $100 million in equity assets under management, as required by the United States Securities and Exchange Commission (SEC). In this article, let麓s concentrate in one particular hedge fund and try to see the principal holdings in its portfolio. I will look into Abner Herrman & Brock LLC, which provides portfolio management for high net worth individuals, endowments, and corporate retirement plans.Recently the fund reported its equity portfolio, as at the end of June. The total value of the portfolio amounted to $331.2 million, up from $311.3 million disclosed at the end of the previous quarter. Consequently, the fund's total return was 6.4% in the last quarter. The filing revealed that at the end of June, the fund added 4 new positions to its equity portfolio, and sold out of 3 other companies. The top ten portfolio holdings as of the end of the quarter represented 30.85%. The largest changes from previous 13-F麓s fillings are in the energy sector (3.5%) followed by the reduction of financials and industrials.In this article, we have selected three companies, in which the fund holds the largest stakes, in terms of market value.The first on the list is Merck & Co. (MRK), in which the fund disclosed a $15.2 million stake with over 263,570 shares. The company is a leading global drugmaker, producing a wide range of prescription drugs in many therapeutic classes in the U.S. and abroad. It has improved earnings per share by 9.6% in the most recent quarter compared to the same quarter a year ago. With respect to price performance, this stock has enjoyed a rise of 26.85% which was in line with the performance of the market. It has a proven commitment to returning cash to investors, with a current dividend yield of 3.0% which is considered good to protect investor麓s purchasing power. Other hedge
No comments:
Post a Comment